Latest News

Category: ASX

See all

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

ASX, News,

Telix is pleased to announce a licence agreement collaboration with Abzena plc (Abzena) for its prostate-specific membrane antigen antibodies...

Read more

Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

ASX, News,

Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS...

Read more

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

ASX, News,

Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG...

Read more